Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
One Glove Group BhdXKLS:5079 4 3-Year EBITDA Growth Rate is 22.80% as of Mar. 2026. GuruFocus rates XKLS:5079 with a GF Score™ of 4/100 and a GF Value™ of RM0.17 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 688 Medical Devices & Instruments companies, One Glove Group Bhd ranks better than 69.48% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 22.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of One Glove Group Bhd was 201.20% per year. The lowest was -146.60% per year. And the median was -8.75% per year.
One Glove Group Bhd (XKLS:5079) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
One Glove Group Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:5079 vs ISRG, BDX, MDLN: 3-Year EBITDA Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, One Glove Group Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
One Glove Group Bhd 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, One Glove Group Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where One Glove Group Bhd's 3-Year EBITDA Growth Rate falls into.
One Glove Group Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 22.80% mean?
One Glove Group Bhd (XKLS:5079) has a 3-Year EBITDA Growth Rate of 22.80% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for One Glove Group Bhd and its competitors. According to the industry distribution chart, One Glove Group Bhd ranks #210 out of 688 companies in the Medical Devices & Instruments industry, placing it in the top 30.5%.
Is One Glove Group Bhd's 3-Year EBITDA Growth Rate too high?
One Glove Group Bhd's current 3-Year EBITDA Growth Rate is 22.80%. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 7.90. One Glove Group Bhd's value of 22.80% is 188.6% above this industry median. Based on the distribution chart, One Glove Group Bhd ranks #210 out of 688 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, One Glove Group Bhd has a GF Score™ of 4/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does One Glove Group Bhd's 3-Year EBITDA Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, One Glove Group Bhd ranks #210 out of 688 companies for 3-Year EBITDA Growth Rate. This puts One Glove Group Bhd in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.90. One Glove Group Bhd's value of 22.80% is 188.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.90, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. One Glove Group Bhd's current 3-Year EBITDA Growth Rate of 22.80% is 188.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for One Glove Group Bhd and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. One Glove Group Bhd's current 3-Year EBITDA Growth Rate is 22.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is One Glove Group Bhd stock overvalued right now?
Based on GuruFocus' analysis, One Glove Group Bhd (XKLS:5079) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.17, compared to a current price of RM0.11 — trading 38.2% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 22.80% and 188.6% above the Medical Devices & Instruments industry median of 7.90. One Glove Group Bhd's overall GF Score™ is 4/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For One Glove Group Bhd (XKLS:5079), the current 3-Year EBITDA Growth Rate is 22.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is One Glove Group Bhd (XKLS:5079) Overvalued in 2026?
Based on GuruFocus' analysis, One Glove Group Bhd stock appears to be undervalued.
The current stock price of RM0.11 is trading 38.2% below its estimated GF Value™ of RM0.17.
GuruFocus considers One Glove Group Bhd to be Possible Value Trap.
Key valuation signals for XKLS:5079:
3-Year EBITDA Growth Rate: 22.80%
GF Value™: RM0.17 vs. price of RM0.11 (38.2% below fair value)
Industry Position: 188.6% above the Medical Devices & Instruments median (#210 of 688)
No single metric tells the full story. See the XKLS:5079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
One Glove Group Bhd is a glove innovator and manufacturer. The company's segment includes Manufacturing, Investment holding, and Others. Its geographical market includes Germany, Malaysia, Turkey, Italy, India, and Others, of which it generates the majority of its revenue from Malaysia. The Company has one core business segment, the Gloves Business, with one factory in operation, the Kamunting Factory.
4GF Score
Get the complete analysis for XKLS:5079
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5079 has been successfully added to your 
